Novartis’ Spin-off of Sandoz’s Generic and Biosimilar Drugs Business

Marco Zingaro Europe Legal Chronicle
Tagged:

Bär & Karrer acted as Swiss legal and tax advisor to Novartis and Sandoz. Cravath represented Novartis as U.S. tax counsel.Novartis has completed the spin-off of…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Marco Zingaro

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here